A model of communicating hydrocephalus based on the spatial and spectral redistribution of intracranial pulsations

  • Michael Egnor1Email author,

    Affiliated with

    • Mark Wagshul2,

      Affiliated with

      • Pat McAllister3,

        Affiliated with

        • Joe Madsen4,

          Affiliated with

          • Rui Zou4,

            Affiliated with

            • Erin McCormack2 and

              Affiliated with

              • Raphael Hazel5

                Affiliated with

                Cerebrospinal Fluid Research20063(Suppl 1):S19

                DOI: 10.1186/1743-8454-3-S1-S19

                Published: 21 December 2006


                Hydrocephalus has traditionally been understood as a disorder of the absorption of CSF. Recent work by Johnston, Cserr and others has challenged the traditional understanding of CSF absorption, and flow MRI studies of Greitz, Bateman, and others suggest that pulsatility plays a central role in the pathogenesis of hydrocephalus. Based on our recent experimental insight into the dynamics of intracranial pulsatility in dogs, and a new model of intracranial dynamics, we discuss a model of the pathophysiology of hydrocephalus in which ventriculomegaly is driven by the redistribution of pulsations in the brain.

                Materials and methods

                We model the cranium as a frequency-sensitive notch filter that suppresses the arterial pulse in the brain. This redistributes the kinetic energy of pulsatility at the heart rate (i.e. cardiac frequency) to smooth, pulseless arterial flow (i.e. zero frequency), which is the cerebral blood flow. This represents the normal spectral distribution of the transfer function between the arterial pulse and the ICP pulse, and is a manifestation of the normal cerebral windkessel mechanism.


                Disturbance of the normal compliance and resistance in the subarachnoid space, such as occurs in communicating hydrocephalus, alters the normal distribution of pulsatility in the cranium. This redistribution can have two distinct manifestations: 1) spatial redistributions in which pulsations are redirected from one part of the cranial cavity to another, such as increased ventricular pulsation at the expense of subarachnoid pulsation, and 2) spectral redistributions in which pulsations are redistributed between flow components at the cardiac frequency and alternate frequency components, such as the enhanced cardiac-related pulsatile flow at the expense of zero-frequency smooth flow. The loss of cerebral blood flow and augmentation of pulsatility is the main manifestation of an impaired windkessel mechanism, and leads to venous stasis, venous hypertension, and reduction in cerebral blood flow.


                We propose that the salient features of clinical and experimental hydrocephalus can be explained as consequences of impairment of the cerebral windkessel mechanism, the mechanism by which the cerebral vasculature renders vascular perfusion of the microvasculature nearly smooth. Asymmetrical obstruction of the CSF pathways causes spatial and spectral redistribution of vascular and CSF pulsations in the cranium. In this model, communicating hydrocephalus is fundamentally an impairment of cerebral blood flow and of the cerebral windkessel mechanism. Ventriculomegaly and CSF malabsorption are the consequences of this impairment. Based on this model, we can suggest significant new and non-intuitive approaches to the treatment of hydrocephalus.

                Authors’ Affiliations

                Department of Neurosurgery, State University of New York at Stony Brook, Health Science
                Department of Radiology, State University of New York at Stony Brook, Health Science Center
                Department of Neurosurgery, Wayne State University School of Medicine
                Department of Neurosurgery, Harvard University
                Department Physiology & Biophysics, State University of New York at Stony Brook, Health Science Center


                © Egnor et al; licensee BioMed Central Ltd. 2006

                This article is published under license to BioMed Central Ltd.